Jump to main content
Jump to site search

Issue 2, 2017
Previous Article Next Article

Targeting Twist expression with small molecules

Author affiliations

Abstract

Twist, as one of the important embryonic transcription factors, regulates epithelial–mesenchymal transition (EMT) and migration in embryo formation and cancer development. Both Twist-1 and Twist-2 are rarely detectable in healthy adult tissues, but are frequently overexpressed in multiple kinds of human cancer tissues, such as breast, prostate, uterus, liver, melanoma, etc. Twist is considered as a crucial EMT inductor and correlated with carcinoma aggression, invasion and metastasis. In the past decades, in-depth investigation has been reported in terms of the role of Twist in cancers; in addition, several kinds of small molecules have played important roles in studying the effect of Twist on cancer development, suggesting that Twist can be regarded as one of the important potential targets for cancer treatment. Hence we provide a brief overview of Twist and several small molecules targeting its expression, highlighting the biological features that make it a charming target for cancer therapy.

Graphical abstract: Targeting Twist expression with small molecules

Back to tab navigation

Publication details

The article was received on 11 Oct 2016, accepted on 01 Dec 2016 and first published on 02 Dec 2016


Article type: Review Article
DOI: 10.1039/C6MD00561F
Citation: Med. Chem. Commun., 2017,8, 268-275
  •   Request permissions

    Targeting Twist expression with small molecules

    H. Pei, Y. Li, M. Liu and Y. Chen, Med. Chem. Commun., 2017, 8, 268
    DOI: 10.1039/C6MD00561F

Search articles by author

Spotlight

Advertisements